The Biotech Growth Trust Plc
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von PR-Newswire bereitgestellt.
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 21 November 2024 was 981.14p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
22 November 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 20 November 2024 was 983.55p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
21 November 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 19 November 2024 was 969.00p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
20 November 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 18 November 2024 was 963.94p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
19 November 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 15 November 2024 was 982.55p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
18 November 2024
For immediate release
15 November 2024
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 18 July 2024 to make market purchases of the Company's own shares up to an aggregate maximum of 4,929,790 that a market total of 75,000 Ordinary shares of 25p each in the capital of the Company were purchased today for cancellation by the Company at a price of 988.98 pence per share.
Following this transaction, the Company hereby notifies the market that the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares bought back for cancellation by the Company following such purchase, and therefore, the total number of voting rights in the Company is 31,519,676. The Company does not currently hold any Ordinary shares in treasury.
The figure of 31,519,676 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Katherine Manson
Frostrow Capital LLP
Tel: 020 3709 8734
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 14 November 2024 was 1044.06p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
15 November 2024
The Biotech Growth Trust PLC
(the "Company")
15 November 2024
Monthly Fact Sheet as at 31 October 2024
The Biotech Growth Trust PLC Fact Sheet as at 31 October 2024 has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and on the Company's website, www.biotechgt.com.
- END-
Frostrow Capital LLP
Company Secretary
Tel: 020 3709 8734
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 13 November 2024 was 1060.93p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
14 November 2024
THE BIOTECH GROWTH TRUST PLC
NET ASSET VALUE
The estimated un-audited net asset value per share, calculated in accordance with the guidelines of the Association of Investment Companies, for The Biotech Growth Trust PLC at the close of business on 12 November 2024 was 1068.54p (cum income).
For and on behalf of the Board
Frostrow Capital LLP
Secretary
13 November 2024
